Health

Pages

What's 'essential' in health care

Mar 2, 2011
The Institute of Medicine is meeting this week to determine what constitutes 'essential' medical care -- which under the health care reform, will be guaranteed to all Americans.
Posted In: Health

The Medi-Medi problem

Mar 1, 2011
As in Medicare and Medicaid. Conflicts in the two government health care programs can drive up costs for states. But change could be on the way.
Posted In: Health

Obama says states must implement health care law

Feb 28, 2011
But Obama told governors today they can design alternative health care programs as long as they meet the law's goals.
Posted In: Health

Is health care to blame for state budget issues?

Feb 24, 2011
Across the country, states are tackling rising budget deficits. And as economics correspondent Chris Farrell explains, health care is at the heart of federal and state deficits.
Posted In: Health

Small sensor could be big breakthrough for heart patients

Feb 23, 2011
An implantable pressure gauge the size of a paperclip may be a big advance in the treatment of heart failure patients.
Posted In: Health

The making of a Russian blockbuster drug

Feb 23, 2011
Not long ago, Arbidol was considered a nearly useless drug. Now, it's a best seller, and a symbol of Russia's efforts to build its pharmaceutical industry, at any cost.
Posted In: Health, Russia

FDA approves wider Lap-Band use for less obese

Feb 17, 2011
The Food and Drug Administration will allow cosmetic drug and device maker Allergan Inc. to market its stomach-restricting Lap-Band to millions of new patients -- patients who are less obese than those currently using the device. Eve Troeh has more.
Posted In: Health, Science

Russia's prescription for prosperity

Feb 16, 2011
American pharmaceutical companies want to build their sales in Russia. Russia is eager to let them so long as they build something else, too. Factories.
Posted In: Health, Russia

Sanofi-Aventis to pay more than $20 bil. for Genzyme

Feb 16, 2011
French pharmaceutical company Sanofi-Aventis will pay more than $20.1 billion for U.S. biotech firm Genzyme. Sanofi will pay $74 per Genzyme share once the deal closes in the second quarter of 2011.
Posted In: Health, Mergers and Acquisitions, Science

Pharma deal: French Sanofi-Aventis to buy U.S. Genzyme

Feb 16, 2011
Wednesday brought an end to the long-awaited deal between French pharmaceutical company Sanofi-Aventis and the U.S. biotech firm Genzyme. Sanofi will buy Genzyme for at least $20.1 billion. But the number could go higher if Genzym's drugs-in-development succeed when they go to market, as Eve Troeh explains.
Posted In: Health, Mergers and Acquisitions, Science

Pages